1
NR566 Week 4 Midterm Final Exam Due 1st February 2026
Complete Actual Exam Questions 1- 100 NR566 Advanced
Pharmacology For Care Of The Family NR 566 Midterm and
Finals Examplify Online Proctored Exam Questions and
Answers | 100% Pass Guaranteed |
NR-566 Advanced Pharmacology for Care of the Family
100 Comprehensive Practice Questions
Academic integrity notice: These are original, expertly crafted practice/study
questions based on NR-566 core competencies and current prescribing
guidelines.
DOMAIN 1: CARDIOVASCULAR PHARMACOLOGY
Q1. A 62-year-old with hypertension and type 2 diabetes is started on lisinopril.
Two weeks later, she develops a persistent dry cough. The MOST appropriate
substitution is:
• A) Amlodipine
• B) Losartan
• C) Metoprolol succinate
• D) Hydrochlorothiazide
✅ Answer: B — Losartan Rationale: ACE inhibitor-induced cough is caused by
bradykinin accumulation. ARBs (losartan, valsartan) block the AT1 receptor
without affecting bradykinin metabolism, so they do NOT cause cough. ARBs
provide equivalent renoprotection in diabetic nephropathy. This is a first-line
substitution per JNC guidelines.
pg. 1
,2
Q2. A patient with heart failure with reduced ejection fraction (HFrEF, EF 30%) is
prescribed carvedilol. Which statement BEST describes the rationale?
• A) It increases heart rate to improve cardiac output
• B) It blocks alpha-1, beta-1, and beta-2 receptors, reducing sympathetic
overdrive and cardiac remodeling
• C) It acts as a positive inotrope
• D) It reduces preload by promoting diuresis
✅ Answer: B — Alpha-1, beta-1, beta-2 blockade reducing sympathetic
overdrive Rationale: Carvedilol is a non-selective beta-blocker with alpha-1
blocking properties. In HFrEF, chronic sympathetic activation causes cardiac
remodeling. Beta-blockers (carvedilol, metoprolol succinate, bisoprolol) reduce
mortality by reversing remodeling. They are started LOW and uptitrated slowly —
NOT during acute decompensation.
Q3. A 70-year-old male with atrial fibrillation and CrCl of 35 mL/min needs
anticoagulation. Which DOAC requires the MOST significant dose adjustment for
renal impairment?
• A) Apixaban
• B) Rivaroxaban
• C) Dabigatran
• D) Warfarin
✅ Answer: C — Dabigatran Rationale: Dabigatran is ~80% renally eliminated
and is CONTRAINDICATED when CrCl <15–30 mL/min (varies by indication).
Apixaban is least renally dependent (~27% renal), making it preferred in renal
impairment. Rivaroxaban is ~33% renal. Warfarin is hepatically metabolized (no
renal adjustment needed but monitoring required).
pg. 2
,3
Q4. A patient with stable angina is prescribed sublingual nitroglycerin (SL NTG).
Patient education should include:
• A) Take with food to reduce GI side effects
• B) May repeat every 5 minutes for up to 3 doses; call 911 if no relief after
first dose
• C) Store in a plastic container at room temperature
• D) Avoid lying down after taking, as it reduces effectiveness
✅ Answer: B — Repeat every 5 minutes × 3, call 911 if unrelieved after first
dose Rationale: SL NTG: dose 0.3–0.4 mg under tongue; may repeat q5min × 3
doses. If pain unresolved after the FIRST dose (some guidelines say after three
doses), call 911. Store in original dark glass bottle (light degrades NTG). Common
side effect: headache and hypotension; sit/lie down after taking.
Q5. Spironolactone is added to a patient's heart failure regimen. The PRIMARY
monitoring concern is:
• A) Hypokalemia
• B) Hyponatremia
• C) Hyperkalemia
• D) Elevated liver enzymes
✅ Answer: C — Hyperkalemia Rationale: Spironolactone is a mineralocorticoid
(aldosterone) antagonist — potassium-sparing diuretic. Combined with ACE
inhibitors/ARBs (also potassium-sparing), risk of life-threatening hyperkalemia is
significant. Monitor K+ and renal function regularly. Avoid in CrCl <30 mL/min or
K+ >5.0 mEq/L.
Q6. A patient on warfarin for atrial fibrillation reports taking ibuprofen regularly
for arthritis pain. The MOST important concern is:
• A) Reduced warfarin levels causing thrombosis
pg. 3
, 4
• B) Enhanced anticoagulation and increased bleeding risk
• C) Reduced renal clearance of warfarin
• D) No clinically significant interaction
✅ Answer: B — Enhanced anticoagulation and bleeding risk Rationale: NSAIDs
+ warfarin: dual mechanism of increased bleeding — NSAIDs inhibit platelet
aggregation AND displace warfarin from protein binding sites (increasing free
warfarin). Additionally, GI mucosal damage increases bleeding risk. Use
acetaminophen for pain management in anticoagulated patients.
Q7. A 55-year-old with hypertension and gout is on thiazide diuretics. His uric acid
level is elevated and he has a gout flare. The MOST appropriate antihypertensive
SUBSTITUTION is:
• A) Amlodipine
• B) Losartan
• C) Metoprolol
• D) Furosemide
✅ Answer: B — Losartan Rationale: Losartan is the ONLY ARB with a uricosuric
effect (blocks URAT-1 renal uric acid transporter), making it uniquely beneficial in
hypertensive patients with gout. Thiazides increase uric acid. Furosemide also
raises uric acid. Losartan provides both BP control and uric acid reduction.
Q8. Which statin has the HIGHEST risk of myopathy due to CYP3A4-mediated drug
interactions?
• A) Rosuvastatin
• B) Pravastatin
• C) Simvastatin
• D) Fluvastatin
pg. 4
NR566 Week 4 Midterm Final Exam Due 1st February 2026
Complete Actual Exam Questions 1- 100 NR566 Advanced
Pharmacology For Care Of The Family NR 566 Midterm and
Finals Examplify Online Proctored Exam Questions and
Answers | 100% Pass Guaranteed |
NR-566 Advanced Pharmacology for Care of the Family
100 Comprehensive Practice Questions
Academic integrity notice: These are original, expertly crafted practice/study
questions based on NR-566 core competencies and current prescribing
guidelines.
DOMAIN 1: CARDIOVASCULAR PHARMACOLOGY
Q1. A 62-year-old with hypertension and type 2 diabetes is started on lisinopril.
Two weeks later, she develops a persistent dry cough. The MOST appropriate
substitution is:
• A) Amlodipine
• B) Losartan
• C) Metoprolol succinate
• D) Hydrochlorothiazide
✅ Answer: B — Losartan Rationale: ACE inhibitor-induced cough is caused by
bradykinin accumulation. ARBs (losartan, valsartan) block the AT1 receptor
without affecting bradykinin metabolism, so they do NOT cause cough. ARBs
provide equivalent renoprotection in diabetic nephropathy. This is a first-line
substitution per JNC guidelines.
pg. 1
,2
Q2. A patient with heart failure with reduced ejection fraction (HFrEF, EF 30%) is
prescribed carvedilol. Which statement BEST describes the rationale?
• A) It increases heart rate to improve cardiac output
• B) It blocks alpha-1, beta-1, and beta-2 receptors, reducing sympathetic
overdrive and cardiac remodeling
• C) It acts as a positive inotrope
• D) It reduces preload by promoting diuresis
✅ Answer: B — Alpha-1, beta-1, beta-2 blockade reducing sympathetic
overdrive Rationale: Carvedilol is a non-selective beta-blocker with alpha-1
blocking properties. In HFrEF, chronic sympathetic activation causes cardiac
remodeling. Beta-blockers (carvedilol, metoprolol succinate, bisoprolol) reduce
mortality by reversing remodeling. They are started LOW and uptitrated slowly —
NOT during acute decompensation.
Q3. A 70-year-old male with atrial fibrillation and CrCl of 35 mL/min needs
anticoagulation. Which DOAC requires the MOST significant dose adjustment for
renal impairment?
• A) Apixaban
• B) Rivaroxaban
• C) Dabigatran
• D) Warfarin
✅ Answer: C — Dabigatran Rationale: Dabigatran is ~80% renally eliminated
and is CONTRAINDICATED when CrCl <15–30 mL/min (varies by indication).
Apixaban is least renally dependent (~27% renal), making it preferred in renal
impairment. Rivaroxaban is ~33% renal. Warfarin is hepatically metabolized (no
renal adjustment needed but monitoring required).
pg. 2
,3
Q4. A patient with stable angina is prescribed sublingual nitroglycerin (SL NTG).
Patient education should include:
• A) Take with food to reduce GI side effects
• B) May repeat every 5 minutes for up to 3 doses; call 911 if no relief after
first dose
• C) Store in a plastic container at room temperature
• D) Avoid lying down after taking, as it reduces effectiveness
✅ Answer: B — Repeat every 5 minutes × 3, call 911 if unrelieved after first
dose Rationale: SL NTG: dose 0.3–0.4 mg under tongue; may repeat q5min × 3
doses. If pain unresolved after the FIRST dose (some guidelines say after three
doses), call 911. Store in original dark glass bottle (light degrades NTG). Common
side effect: headache and hypotension; sit/lie down after taking.
Q5. Spironolactone is added to a patient's heart failure regimen. The PRIMARY
monitoring concern is:
• A) Hypokalemia
• B) Hyponatremia
• C) Hyperkalemia
• D) Elevated liver enzymes
✅ Answer: C — Hyperkalemia Rationale: Spironolactone is a mineralocorticoid
(aldosterone) antagonist — potassium-sparing diuretic. Combined with ACE
inhibitors/ARBs (also potassium-sparing), risk of life-threatening hyperkalemia is
significant. Monitor K+ and renal function regularly. Avoid in CrCl <30 mL/min or
K+ >5.0 mEq/L.
Q6. A patient on warfarin for atrial fibrillation reports taking ibuprofen regularly
for arthritis pain. The MOST important concern is:
• A) Reduced warfarin levels causing thrombosis
pg. 3
, 4
• B) Enhanced anticoagulation and increased bleeding risk
• C) Reduced renal clearance of warfarin
• D) No clinically significant interaction
✅ Answer: B — Enhanced anticoagulation and bleeding risk Rationale: NSAIDs
+ warfarin: dual mechanism of increased bleeding — NSAIDs inhibit platelet
aggregation AND displace warfarin from protein binding sites (increasing free
warfarin). Additionally, GI mucosal damage increases bleeding risk. Use
acetaminophen for pain management in anticoagulated patients.
Q7. A 55-year-old with hypertension and gout is on thiazide diuretics. His uric acid
level is elevated and he has a gout flare. The MOST appropriate antihypertensive
SUBSTITUTION is:
• A) Amlodipine
• B) Losartan
• C) Metoprolol
• D) Furosemide
✅ Answer: B — Losartan Rationale: Losartan is the ONLY ARB with a uricosuric
effect (blocks URAT-1 renal uric acid transporter), making it uniquely beneficial in
hypertensive patients with gout. Thiazides increase uric acid. Furosemide also
raises uric acid. Losartan provides both BP control and uric acid reduction.
Q8. Which statin has the HIGHEST risk of myopathy due to CYP3A4-mediated drug
interactions?
• A) Rosuvastatin
• B) Pravastatin
• C) Simvastatin
• D) Fluvastatin
pg. 4
